• Contact Us
  • Submit RFI/RFP
  • Trust Center
  • Ethics Hotline (report a violation)
  • LIFE SCIENCES
  • HEALTHCARE
  • RESOURCES
    • The Future Prescription
    • Blog
    • Case Studies & Publications
    • Events
    • Press Releases
  • ABOUT
    • Leadership
    • Board of Directors
    • Our Vision and Mission
    • Careers
    • Locations
  • SIGN IN
    • TriNetX LIVE™
    • EVIDEX®
  • Trial Design
  • Datasets & Analytics
  • Non-US Oncology
  • RWE Generation
  • Drug Safety

TriNetX Unveils State-of-the-Art Analytics Solutions for Use with Its Clinical Data

May 21, 2018 | Press Releases

Enables Researchers to Hypothesize and Answer Complex Research Questions About Patient Outcomes & Treatment Effectiveness  BALTIMORE, MD – ISPOR 2018 – May 21, 2018 – TriNetX™, the global health research network, today announced the availability of TriNetX...

ISPOR 2018 – “Using Real World Data to Establish an Optimal Treatment Target for Hba1c in Diabetes Type 2”

May 19, 2018 | Events, Published Research

Presented at ISPOR 2018, this poster investigates using real world data to establish an optimal treatment target for Hba1c in diabetes type 2. Stapff MP, Palm S, Stacey J TriNetX Inc., Cambridge, MA, USA ISPOR 2018 Download the poster...

ISPOR 2018 – “A Real-World Data Analysis Evaluating the Time to Glycemic Control After Initiation of Basal Insulin in Type 2 Diabetic Patients”

May 19, 2018 | Events, Published Research

Presented at ISPOR 2018, this poster is a real-world data analysis evaluating the time to glycemic control after initiation of basal insulin in type 2 diabetic patients. Stacey J, Hilderbrand S, Stapff MP TriNetX Inc., Cambridge, MA, USA ISPOR 2018 Download the poster...

ISPOR 2018 – “Comparison of Bleeding Events, Strokes, and Myocardial Infarcts on Warfarin or Dabigatran for Treatment of Atrial Fibrillation: Results of a Real-World Data Analysis”

May 19, 2018 | Events, Published Research

Presented at ISPOR 2018, this poster is a comparison of bleeding events, strokes, and myocardial infarcts on warfarin or dabigatran for treatment of atrial fibrillation: results of a real-world data analysis. Stapff MP TriNetX Inc., Cambridge, MA, USA ISPOR 2018...

A Six-Year Approach To Improving Clinical Trial Efficiencies

May 17, 2018 | News

Clinical Leader, May 2, 2018 Learn more

Bulgaria’s Puls Hospital Aiming for Earlier Clinical Trial Involvement with TriNetX

May 15, 2018 | Press Releases

LONDON, 15 May, 2018 — Puls Hospital, the only private multi-profile hospital in the Blagoevgrad region of Bulgaria, has announced it is partnering with TriNetX to expand its participation in clinical trials by getting involved earlier in the process. “We are looking...

TriNetX to Present at ISPOR 2018 on the Use of Real-World Data as an Established Method for Evaluating Safety & Comparative Effectiveness

May 14, 2018 | Events, Press Releases

CAMBRIDGE, MA – May 14, 2018 – TriNetX™, the global health research network, today announced that it willpresent three posters on the use of real-world data from its federated electronic medical record (EMR)-based network as an established methodology for evaluating...

Somerset Partnership Seeks to Increase Patient Participation in Clinical Trials with TriNetX

Apr 25, 2018 | Press Releases

LONDON, April 25, 2018— Somerset Partnership NHS Foundation Trust, which serves a patient population of 650,000 in the south west region of the U.K., is the first integrated mental and community health trust in the NHS to join TriNetX, with the goal of expanding the...

Tufts Medical Center Joins the TriNetX Network for Enhanced Insight into their Clinical Data

Apr 18, 2018 | Press Releases

Cambridge, MA, April 18, 2018 — Tufts Medical Center (Tufts MC), a 415-bed academic medical center located in downtown Boston, has joined the TriNetX Network to enhance its clinical trial process. Tufts MC brings an additional one million patient lives to the global...

Pfizer Joins the TriNetX Global Health Research Network Formed to Improve Clinical Trial Design and Accelerate the Development of New Drugs

Apr 10, 2018 | Press Releases

Cambridge, MA, April 10, 2018 — Pfizer Inc., a world leader in clinical trial innovation, has joined the TriNetX global health research network. As a member, Pfizer will have access to clinical data from TriNetX’s network of healthcare organizations to support...
« Older Entries
Next Entries »

SOLUTIONS

Clinical Trial Design & Optimization

Data Sets & Analytics

Non-US Oncology

Insights & Evidence Generation

Drug Safety & Pharmacovigilance

WHO WE SERVE

Life Sciences

Healthcare Organizations

RESOURCES

Explore TriNetX RWD

Conferences

Webinars

Publications

Case Studies

ENTERPRISE

Leadership

Board of Directors

Careers

Locations

EMAIL OPT-IN

Get the latest on product updates, services, events, expert insights, and top industry trends.

Subscribe now

ABOUT TRINETX, LLC

TriNetX operates the world’s broadest federated network of real-world data in partnership with healthcare providers and applies intelligence that accelerates innovation across the healthcare ecosystem. Through its self-service, HIPAA-, GDPR-, and LGPD-compliant platform of federated deidentified and anonymous electronic health record datasets and consulting partnerships, TriNetX empowers its global community to improve clinical trial protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation.

TriNetX, LLC complies with all applicable privacy laws. For more information please visit our Trust Center.

FOLLOW US

LinkedIn
© TriNetX, LLC All Rights Reserved.
Terms of Use
Privacy & Cookies
Do not sell or share my personal information